Memantine LEK
Država: Evropska unija
Jezik: danščina
Source: EMA (European Medicines Agency)
Navodilo za uporabo
(PIL)
16-11-2020
Lastnosti izdelka
(SPC)
16-11-2020
Javno poročilo o oceni
(PAR)
29-04-2013
Aktivna sestavina:
memantinhydrochlorid
Dostopno od:
Pharmathen S.A.
Koda artikla:
N06DX01
INN (mednarodno ime):
memantine
Terapevtska skupina:
Psychoanaleptics, , Andre demensmedicin
Terapevtsko območje:
Alzheimers sygdom
Terapevtske indikacije:
Behandling af patienter med moderat til svær Alzheimers sygdom.
Povzetek izdelek:
Revision: 5
Status dovoljenje:
autoriseret
Datum dovoljenje:
2013-04-21
Navodilo za uporabo
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Preberite celoten dokument
Lastnosti izdelka
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Preberite celoten dokument
